Year: 2018

Justin Ichida regularly gets emails from strangers asking an urgent question: Will your research on ALS be done in time to save my life? “I don’t really know them, but they tell me their whole story,” said Ichida, a scientist with the USC Stem Cell program. “They’ll ask, ‘How long is it going to take…Continue Reading The USC scientist who aims to beat ALS, and the patients cheering him on

In this 360 video tour of USC’s stem cell research center, Dr. Justin Ichida and Dr. Seth Ruffins welcome you to the second floor, which has four core facilities for therapeutic screening, flow cytometry, stem cell engineering and microscopy….Continue Reading Justin Ichida hosts 360 video tour of USC’s stem cell research center

In USC’s Department of Stem Cell Biology and Regenerative Medicine, half of the faculty members are assistant professors, poised at the threshold of their careers in biomedical research. One of these promising pioneers, ALS researcher Justin Ichida, has been chosen as the first of four USC Richard N. Merkin Scholars. Ichida and his fellow scholars, yet…Continue Reading USC Stem Cell scientist Justin Ichida named inaugural Richard N. Merkin Scholar

In the article “How Nanci Ryder’s ALS Fight Sparked a Medical Breakthrough” in The Hollywood Reporter, Justin Ichida gives an update on the lab’s progress….Continue Reading Justin Ichida publishes research update in The Hollywood Reporter

ALS and frontotemporal dementia (FTD) are two neurodegenerative diseases with a toxic relationship, according to a new USC Stem Cell study published in Nature Medicine. In the study, Yingxiao TK Shi and Shaoyu Sebastian Lin in the laboratory of Justin Ichida describe how a mutation in a gene, called C9ORF72, leads to toxicity in nerve…Continue Reading The toxic relationship between ALS and frontotemporal dementia